Tubeless Intersegmentectomy Plane Identification With Fluorography

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-85
SponsorThe Second Hospital of Shandong University

About this trial

Background: We aimed to evaluate the combination of inflation- deflation method and fluorography with the ICG injection in the tubeless minimally invasive segmentectomy (no intubation, VATS or Robotic).

Methods: A one- armed, prospective randomized controlled study was designed. The intersegmental plane was not so clear during the tubeless minimally invasive segmentectomy, and the presentation of the plane sometimes cost more time. This study will evaluate consecutive patients with the combination of inflation- deflation method and fluorography with the ICG injection.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

cardio- pulmonary function can tolerate the minimally invasive surgery (including VATS and robotic surgery);

benign pulmonary lesion considering for segmentectomy;

≤2cm pulmonary adenocarcinoma with ground- glass components, considering for segmentectomy.

Disqualifiers

cardio- pulmonary function can not tolerate the minimally invasive surgery (including VATS and robotic surgery);

segmentectomy is not considered as the surgery plan.

Trial design

Design model

Single group

Treatments tested in this trial

  • inflation- deflation line combined with ICG fluorography

    Procedure/Surgery

    Identification of the intersegmental plane using inflation- deflation line combined with ICG fluorography under the status of tubeless

Treatment groups

60 Participants
are divided into 1 treatment group
Group A: inflation- deflation line combined with ICG fluorographyExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

time of description and management of the intersegmental plane

time of description and management of the intersegmental plane

Time frame
during surgery
2

perioperative complication rate

perioperative complication rate

Time frame
within 7 days after surgery
3

incisal margin of the tumor

incisal margin of the tumor

Time frame
during surgery

Secondary outcomes

1

disease- free survival

DFS

Time frame
within 5 years after surgery

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.